What does quality surgery for UGI cancer look like in 2021?
厂辫别补办别谤:听Sheraz R. Markar PhD (Imperial), PhD (Karolinska), MRCS, MSc, MA
Sheraz R. Markar is senior oesophago-gastric fellow at Oxford University Hospital Trust, UK and assistant professor at Karolinska Institutet, Sweden. He qualified from the University of Cambridge in 2007, and has worked clinically and academically primarily in the field of oesophageal and gastric cancer, undertaking fellowships in Seattle USA, Karolinska Institutet Stockholm and Lille, France. He has undertook his first PhD at Imperial College London, using mass spectrometry for breath analysis to diagnose oesophageal and gastric cancer. He undertook his second PhD at Karolinska Institutet, in using national datasets to identify areas of improvement in surgical therapy for oesophageal cancer. He has published over 230 peer publications and given 120 international presentations. His research interests include evidence synthesis, novel design in surgical clinical trials, challenges to cancer survivorship and surveillance, and non-invasive cancer diagnosis with volatile organic compounds.
Zoom link: